Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Linder

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Blood|February 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemiaAndreas Linder, Daniel Nixdorf, Niklas Kuhl, et al.
Nature Methods|December 24, 2021
Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4<sup>+</sup> T cells allows complex functional analysesManuel Albanese, Adrian Ruhle, Jennifer Mittermaier, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Gastroenterology|February 15, 2026
STING ablation in T cells is required for the efficacy of STING agonists in CAR-T cell immunotherapy of pancreatic cancerIgnazio Piseddu, Rebekka Endres, Fabian Lanzl, et al.
Journal for Immunotherapy of Cancer|December 4, 2025
TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicityMonika Sponheimer, Kieron White, Michelle Ulrich, et al.
Nature Communications|February 24, 2022
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infectionKami Pekayvaz, Alexander Leunig, Rainer Kaiser, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Blood|February 26, 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemiaAndreas Linder, Daniel Nixdorf, Niklas Kuhl, et al.
Nature Methods|December 24, 2021
Rapid, efficient and activation-neutral gene editing of polyclonal primary human resting CD4<sup>+</sup> T cells allows complex functional analysesManuel Albanese, Adrian Ruhle, Jennifer Mittermaier, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Gastroenterology|February 15, 2026
STING ablation in T cells is required for the efficacy of STING agonists in CAR-T cell immunotherapy of pancreatic cancerIgnazio Piseddu, Rebekka Endres, Fabian Lanzl, et al.
Journal for Immunotherapy of Cancer|December 4, 2025
TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicityMonika Sponheimer, Kieron White, Michelle Ulrich, et al.
Nature Communications|February 24, 2022
Protective immune trajectories in early viral containment of non-pneumonic SARS-CoV-2 infectionKami Pekayvaz, Alexander Leunig, Rainer Kaiser, et al.
Pageof 2